Prostatic small-cell neuroendocrine carcinoma with disease progression monitored by measurement of serum progastrin-releasing peptide.
Yashi
M
M
Department of Urology, Ohmori Hospital, Hiraka-gun, Akita-ken, Japan. yashi@netoomori.gr.jp
Muraishi
O
O
Tokue
A
A
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood*; D018288:Carcinoma, Small Cell / Q000097:blood / Q000175:diagnosis*; D018450:Disease Progression; D006801:Humans; D008297:Male; D010446:Peptide Fragments / Q000097:blood*; D010455:Peptides / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*; D011994:Recombinant Proteins / Q000097:blood*
D014408:Biomarkers, Tumor; D010446:Peptide Fragments; D010455:Peptides; D011994:Recombinant Proteins; C087079:pro-gastrin-releasing peptide (31-98)